Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fatigue Measurements in Systemic Lupus Erythematosus.
Barbacki A, Petri M, Aviña-Zubieta A, Alarcón GS, Bernatsky S. Barbacki A, et al. J Rheumatol. 2019 Nov;46(11):1470-1477. doi: 10.3899/jrheum.180831. Epub 2019 Feb 1. J Rheumatol. 2019. PMID: 30709953
Damage Trajectories in Systemic Sclerosis Using Group-Based Trajectory Modeling.
Barbacki A, Baron M, Wang M, Zhang Y, Stevens W, Sahhar J, Proudman S, Nikpour M, Man A; Australian Scleroderma Interest Group and the Canadian Scleroderma Research Group. Barbacki A, et al. Arthritis Care Res (Hoboken). 2023 Mar;75(3):640-647. doi: 10.1002/acr.24873. Epub 2022 Nov 15. Arthritis Care Res (Hoboken). 2023. PMID: 35226416
A case of severe Pembrolizumab-induced neutropenia.
Barbacki A, Maliha PG, Hudson M, Small D. Barbacki A, et al. Anticancer Drugs. 2018 Sep;29(8):817-819. doi: 10.1097/CAD.0000000000000661. Anticancer Drugs. 2018. PMID: 29889673
Prediction of damage trajectories in systemic sclerosis using group-based trajectory modelling.
Baron M, Barbacki A, Man A, de Vries-Bouwstra JK, Johnson D, Stevens W, Osman M, Wang M, Zhang Y, Sahhar J, Ngian GS, Proudman S, Nikpour M; Australian Scleroderma Interest Group and the Canadian Scleroderma Research Group. Baron M, et al. Among authors: barbacki a. Rheumatology (Oxford). 2023 Sep 1;62(9):3059-3066. doi: 10.1093/rheumatology/kead002. Rheumatology (Oxford). 2023. PMID: 36625513 Free PMC article.